Lemtrada 58468-0200

Generic: Alemtuzumab

Product NDC

58468-0200

Manufacturer: Genzyme Corporation
Dosage Form: Injection, Solution, Concentrate
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: November 18, 2014
Listing Expires: December 31, 2026
Application: BLA103948

Need to source Lemtrada? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Alemtuzumab	12 mg/1.2mL

Drug Class

CD52-directed Cytolytic Antibody [EPC]CD52-directed Antibody Interactions [MoA]CD52-directed Cytolytic Antibody [EPC]

Packaging Options(1)

58468-0200-01

1 VIAL, SINGLE-USE in 1 CARTON (58468-0200-1) / 1.2 mL in 1 VIAL, SINGLE-USE

View →